LobbyingHenry Meds lobbying by quarter
Henry Meds's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q1 2025; the issues it reports most are Pharmacy.
Henry Meds
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $60K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$360K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)6 reports
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rubicon Advisors | $360K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| WILLIAM BURKE | Lobbyist | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Rubicon Advisors | $60K |
| 04/23for Q1 | Rubicon Advisors | $60K |
| 01/18for Q4 2025 | Rubicon Advisors | $60K |
| 25/10/21for Q3 2025 | Rubicon Advisors | $60K |
| 25/07/19for Q2 2025 | Rubicon Advisors | $60K |
| 25/05/20for Q1 2025 | Rubicon Advisors | $60K |
| 25/03/10for Q1 2025 | Rubicon Advisors | Under $5,000 |